AtriCure (ATRC) Sɔɔtɔ Fɔrɛkɛst
Nɔnyɔ nyɛ$58.35Nɔɔ 25 Gbo 2026 19:59 UTC
Nyuɛ-3.98%
AI forecast: ATRC
AI bɔɔ target price fɔ trading day tɛnɛ, week ɛnɛ ɛkpɔ month ɛnɛ ɛkɛ. Change bɔɔ latest price lɛ. Statistical estimates lɛ, not investment advice.
Nɔnyɔ ɔhɛ 6 dɛnɛ a akɛ
Premium shows the AI's price targets for 1 day, 1 week and 1 month for this and every other stock.
Unlock Premium🔒 Nɔ nyɛmɛ nyɛ nyɛmɛ
The forecast track record — every past forecast next to the actual close — is part of Premium.
Unlock PremiumƐŋɛ Nɛ Kɔmpɔni A
AtriCure, Inc. (ATRC) manufactures and sells surgical devices designed for precise soft tissue incisions. The company’s bipolar ablation system is used in cardiothoracic surgery as a standard alternative treatment for creating areas of heart tissue that block abnormal electrical impulses.
